Brenner Erin K. - Insider Non-Derivative Transactions at Pear Therapeutics, Inc. (PEAR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 20, 2023, Brenner Erin K.'s relationship to Pear Therapeutics, Inc. (PEAR) is Officer (Chief Product Dev. Officer), and currently has 52,000 shares of Common Stock, and 43,310 shares of Class A Common Stock.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other PEAR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Brenner Erin K. - Insider Non-Derivative Transactions of PEAR Common Stock

Brenner Erin K. - Insider Non-Derivative Transactions of PEAR Class A Common Stock

Brenner Erin K. - Insider Non-Derivative Transactions at PEAR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 21, 2023	Sell -- (Class A Common Stock)	8690	1.13	43310
Jan 15, 2023	M -- (Common Stock)	22000	0	52000